)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Zhejiang Huahai Pharmaceutical
Zhejiang Huahai Pharmaceutical (600521) investor relations material
Zhejiang Huahai Pharmaceutical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary30 Apr, 2026
Executive summary
Revenue for 2025 was RMB 8.59 billion, down 10.06% year-over-year; net profit attributable to shareholders was RMB 266 million, down 76.19% year-over-year.
Decline in profit mainly due to intensified price competition in domestic formulations, stable but pressured API margins, increased R&D expenses (up RMB 240 million), and higher forex losses (up RMB 110 million).
Comprehensive gross margin was 60.16%, down 1.75 percentage points year-over-year.
The company remains a leading supplier of cardiovascular and CNS APIs globally, with a robust international and domestic sales network.
Financial highlights
Operating income: RMB 8.59 billion, down 10.06% year-over-year.
Net profit attributable to shareholders: RMB 266 million, down 76.19% year-over-year.
Operating cash flow: RMB 1.23 billion, down 43.38% year-over-year.
R&D investment: RMB 1.48 billion, 17.23% of revenue.
Basic EPS: RMB 0.18, down 76.62% year-over-year.
Outlook and guidance
2026 sales revenue target set at RMB 9.2 billion, with focus on strengthening API and formulation integration, accelerating innovative drug commercialization, and expanding global presence.
Strategic emphasis on high-value APIs, differentiated generics, and innovative biologics.
Continued investment in R&D and international market expansion.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Zhejiang Huahai Pharmaceutical
- Net profit jumped 35.90% on a one-time gain, but core profit and revenue declined year-over-year.600521
Q1 202630 Apr 2026 - Net profit jumped 34.74% on 14.91% revenue growth, with robust R&D and strong cash flow.600521Q4 202419 Dec 2025
- Revenue and profit declined sharply amid price pressure and higher R&D, but innovation advanced.600521Q2 202519 Dec 2025
- Revenue and profit fell significantly amid higher R&D costs and market competition.600521Q3 202531 Oct 2025
- Net profit jumped 85.09% in Q3 2024 on robust sales and improved margins.600521Q3 202413 Jun 2025
- Net profit surged 31.60% on 19.43% revenue growth, led by new products and global expansion.600521Q2 202413 Jun 2025
- Net profit rose 9.81% year-over-year despite a 5.21% revenue decline in Q1 2025.600521Q1 20256 Jun 2025
Next Zhejiang Huahai Pharmaceutical earnings date
Q2 202628 Aug, 2026
Zhejiang Huahai Pharmaceutical
Next Zhejiang Huahai Pharmaceutical earnings date
Q2 202628 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage